Database

Startups

Main Industry
Health Care
Main Product/Service
EliteCell’s product portfolio includes the “EliteGro™” human‑platelet‑lysate (hPL) line—animal‑serum‑free and xenogeneic‑free cell‑culture supplements for research and commercial cell‑expansion applications; the “EL837” serum‑free lymphocyte culture mediu
Founded Year
2017
Unified Business No.
55627837
Status
Active
Number of Employees
0
Total Paid-in Capital
3,354,480 (NT$)
Location of Company
Taiwan , New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
Biomedical EliteCell Corp. focuses on providing safe and effective cell‑culture products for the cell‑therapy industry and research community. With over a decade of cGMP manufacturing experience in the cell supplement market, the company collaborates with



More ↓

Similar Companies